Alibaba Health Information Technology : RESULTS OF THE SPECIAL GENERAL MEETING HELD ON MARCH 1, 2021

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED ڛԢ਄ੰڦࢹҦஔϞࠢʮ̡

(Incorporated in Bermuda with limited liability)

(Stock code: 00241)

RESULTS OF THE SPECIAL GENERAL MEETING

HELD ON MARCH 1, 2021

The board (the ''Board'') of directors (the ''Directors'') of Alibaba Health Information Technology Limited (the ''Company'') is pleased to announce that, on March 1, 2021, the Company held its special general meeting (the ''SGM'') at which the ordinary resolution set out in the notice of special general meeting (the ''Notice'') dated February 8, 2021 was duly passed by way of poll.

Reference is made to the circular (the ''Circular'') of the Company dated February 8, 2021 in respect of the proposed revision of the existing annual cap of RMB825 million for the year ending March 31, 2021 under the 2018 Framework Technical Services Agreement. Capitalized terms used herein shall have the same meanings as defined in the Circular unless the context requires otherwise.

RESULTS OF THE SGM

The Board is pleased to announce that at the SGM held at Holiday Inn Express Hong Kong Causeway Bay, Meeting Room I & II, 7/F., 33 Sharp Street East, Causeway Bay, Hong Kong on Monday, March 1, 2021 at 10 : 30 a.m., the ordinary resolution set out in the Notice (the ''Resolution'') was duly passed by way of poll. The poll results in respect of the Resolution were as follows:

Notes:

• (1) The full text of the Resolution is set out in the Notice.

• (2) As at the date of the SGM:

  • (a) the total number of Shares in issue was 13,456,060,292. Since the last monthly return submitted by the Company under Rule 13.25B of the Listing Rules, the Company had issued a total of

    419,750 Shares due to the exercise of share options by certain employees of the Company under the Company's share award scheme. Such share options were not exercised by a Director and hence a next day disclosure return was not submitted by the Company under Rule 13.25A(1) of the Listing Rules;

  • (b) Perfect Advance Holding Limited, Ali JK Nutritional Products Holding Limited and Antfin

    (Hong Kong) Holding Limited, which hold a total of 8,657,515,415 Shares, representing approximately 64.34% of the issued share capital of the Company, have abstained from voting at the SGM. Save as disclosed above, no other Shareholder is required to abstain from voting on the Resolution contemplated thereunder;

  • (c) the total number of Shares entitling the Shareholders to attend and vote for or against the Resolution at the SGM was 4,798,544,877; and

  • (d) the total number of Shares entitling the Shareholders to attend and vote only against the Resolution at the SGM was nil.

• (3) Tricor Secretaries Limited, the Company's branch share registrar and transfer office in Hong Kong, was appointed as the scrutineer at the SGM for the purpose of vote-taking in respect of the

  Resolution.

As more than 50% of the total votes were cast in favour of the Resolution, such Resolution was duly passed as ordinary resolution of the Company.

For and on behalf of the Board Alibaba Health Information Technology Limited

ZHU Shunyan

Chairman and Chief Executive Officer

Hong Kong, March 1, 2021

As at the date of this announcement, the Board comprises seven Directors, of which (i) two are executive Directors, namely Mr. ZHU Shunyan and Mr. TU Yanwu; (ii) two are non-executive Directors, namely Mr. WU Yongming and Mr. XU Hong; and (iii) three are independent non-executive Directors, namely Mr. LUO Tong, Mr. WONG King On, Samuel and Ms. HUANG Yi Fei (Vanessa).

*

English name for identification purpose only